Access to innovative cancer drugs: Divergent outcomes of HTA bodies' appraisals in France, Germany and the United Kingdom impact on the availability of new medicines. (February 2017) - Hartmann, M.; Droeschel, D.; Vollmer, L.; De Paz, B.; Walzer, S.